PTPRC and hepatocellular carcinoma: On the other hand, CD45 has been used to target the surface of noncancerous cells for negative enrichment during CTC isolation.36 In this study, we identified a subpopulation of CTCs expressed CD45 (CD45+ CTCs) in blood samples from cancer patients with CRC, NSCLC or HCC.